Clade 2.3.4.4b H5N1 neuraminidase has a long stalk, which is in contrast to most highly pathogenic H5N1 viruses circulating between 2002 and 2020
- PMID: 40008897
- PMCID: PMC11980542
- DOI: 10.1128/mbio.03989-24
Clade 2.3.4.4b H5N1 neuraminidase has a long stalk, which is in contrast to most highly pathogenic H5N1 viruses circulating between 2002 and 2020
Abstract
Since 2020, H5N1 highly pathogenic avian influenza (HPAI) viruses of clade 2.3.4.4b have been rapidly spreading in wild birds but have also caused a large number of mammalian infections and more than 70 known human cases. Importantly, this H5N1 clade has also crossed the species barrier into dairy cattle in the US in late 2023/early 2024. The neuraminidase (NA) protein of the N1 subtype can feature truncations in its stalk domain, which have been identified as putative virulence factors in poultry but seem to have a negative impact on transmission in mammals. Since its emergence, the vast majority of HPAI H5N1 A/goose/Guangdong/1/1996-lineage isolates have featured this truncated version of the NA stalk domain. Here, we report that this changed with the 2020 expansion of clade 2.3.4.4b H5N1 and that the majority of isolates-including the strains circulating in dairy cattle-feature a long NA stalk domain.IMPORTANCEWhile the truncated version of the N1 neuraminidase stalk domain may be associated with increased virulence in poultry, the long version of the stalk domain has been associated with increased transmissibility in mammals. The vast majority of highly pathogenic H5N1 of clade 2.3.4.4b that is currently circulating globally features the long stalk version of the neuraminidase, which may increase the risk for these viruses to become human-to-human transmissible.
Keywords: H5N1; influenza; neuraminidase; neuraminidase stalk.
Conflict of interest statement
The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays, NDV-based SARS-CoV-2 vaccines, influenza virus vaccines, and influenza virus therapeutics, which list F.K. as co-inventor, and some of these patents have been licensed entitling F.K. to royalty payments. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2 and another company, CastleVax, to develop SARS-CoV-2 vaccines. F.K. is a co-founder and scientific advisory board member of CastleVax. F.K. has consulted for Merck, Curevac, GSK, Seqirus, and Pfizer and is currently consulting for 3rd Rock Ventures, Gritstone Bio, and Avimex. The Krammer laboratory is collaborating with Dynavax on influenza vaccine development.
Figures


Similar articles
-
An Update on Highly Pathogenic Avian Influenza A(H5N1) Virus, Clade 2.3.4.4b.J Infect Dis. 2024 Sep 23;230(3):533-542. doi: 10.1093/infdis/jiae379. J Infect Dis. 2024. PMID: 39283944 Review.
-
Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024.Emerg Microbes Infect. 2025 Dec;14(1):2469643. doi: 10.1080/22221751.2025.2469643. Epub 2025 Mar 11. Emerg Microbes Infect. 2025. PMID: 39964293 Free PMC article.
-
Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission.mBio. 2024 Dec 11;15(12):e0254224. doi: 10.1128/mbio.02542-24. Epub 2024 Nov 13. mBio. 2024. PMID: 39535188 Free PMC article. Review.
-
A molecular and antigenic survey of H5N1 highly pathogenic avian influenza virus isolates from smallholder duck farms in Central Java, Indonesia during 2007-2008.Virol J. 2011 Sep 7;8:425. doi: 10.1186/1743-422X-8-425. Virol J. 2011. PMID: 21896207 Free PMC article.
-
Genetic diversity of highly pathogenic avian influenza H5N6 and H5N8 viruses in poultry markets in Guangdong, China, 2020-2022.J Virol. 2025 Jan 31;99(1):e0114524. doi: 10.1128/jvi.01145-24. Epub 2024 Dec 4. J Virol. 2025. PMID: 39629997 Free PMC article.
Cited by
-
Highly Pathogenic Avian Influenza (H5N1) Clade 2.3.4.4b in Cattle: A Rising One Health Concern.Animals (Basel). 2025 Jul 3;15(13):1963. doi: 10.3390/ani15131963. Animals (Basel). 2025. PMID: 40646862 Free PMC article. Review.
-
A clade 2.3.4.4b H5N1 virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins.bioRxiv [Preprint]. 2025 Aug 14:2025.08.14.670375. doi: 10.1101/2025.08.14.670375. bioRxiv. 2025. PMID: 40832286 Free PMC article. Preprint.
-
Highly pathogenic avian influenza H5N1: history, current situation, and outlook.J Virol. 2025 Apr 15;99(4):e0220924. doi: 10.1128/jvi.02209-24. Epub 2025 Mar 27. J Virol. 2025. PMID: 40145745 Free PMC article. Review.
-
H5N1 2.3.4.4b: a review of mammalian adaptations and risk of pandemic emergence.J Gen Virol. 2025 Jun;106(6):002109. doi: 10.1099/jgv.0.002109. J Gen Virol. 2025. PMID: 40465371 Free PMC article. Review.
-
Clade 2.3.4.4b highly pathogenic H5N1 influenza viruses from birds in China replicate effectively in bovine cells and pose potential public health risk.Emerg Microbes Infect. 2025 Dec;14(1):2505649. doi: 10.1080/22221751.2025.2505649. Epub 2025 May 30. Emerg Microbes Infect. 2025. PMID: 40353570 Free PMC article.
References
-
- Günther A, Krone O, Svansson V, Pohlmann A, King J, Hallgrimsson GT, Skarphéðinsson KH, Sigurðardóttir H, Jónsson SR, Beer M, Brugger B, Harder T. 2022. Iceland as stepping stone for spread of highly pathogenic avian influenza virus between Europe and North America. Emerg Infect Dis 28:2383–2388. doi:10.3201/eid2812.221086 - DOI - PMC - PubMed
-
- Alkie TN, Lopes S, Hisanaga T, Xu W, Suderman M, Koziuk J, Fisher M, Redford T, Lung O, Joseph T, Himsworth CG, Brown IH, Bowes V, Lewis NS, Berhane Y. 2022. A threat from both sides: multiple introductions of genetically distinct H5 HPAI viruses into Canada via both East Asia-Australasia/Pacific and Atlantic flyways. Virus Evol 8:veac077. doi:10.1093/ve/veac077 - DOI - PMC - PubMed
-
- Caserta LC, Frye EA, Butt SL, Laverack M, Nooruzzaman M, Covaleda LM, Thompson AC, Koscielny MP, Cronk B, Johnson A, Kleinhenz K, Edwards EE, Gomez G, Hitchener G, Martins M, Kapczynski DR, Suarez DL, Alexander Morris ER, Hensley T, Beeby JS, Lejeune M, Swinford AK, Elvinger F, Dimitrov KM, Diel DG. 2024. Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle. Nature 634:669–676. doi:10.1038/s41586-024-07849-4 - DOI - PMC - PubMed
-
- Burrough ER, Magstadt DR, Petersen B, Timmermans SJ, Gauger PC, Zhang J, Siepker C, Mainenti M, Li G, Thompson AC, Gorden PJ, Plummer PJ, Main R. 2024. Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024. Emerg Infect Dis 30:1335–1343. doi:10.3201/eid3007.240508 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical